BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Johnson JM, Lai SY, Cotzia P, Cognetti D, Luginbuhl A, Pribitkin EA, Zhan T, Mollaee M, Domingo-Vidal M, Chen Y, Campling B, Bar-Ad V, Birbe R, Tuluc M, Martinez Outschoorn U, Curry J. Mitochondrial Metabolism as a Treatment Target in Anaplastic Thyroid Cancer. Semin Oncol 2015;42:915-22. [PMID: 26615136 DOI: 10.1053/j.seminoncol.2015.09.025] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
Number Citing Articles
1 Gong Y, Xu F, Deng L, Peng L, Teekaraman Y. Recognition of Key Genes in Human Anaplastic Thyroid Cancer via the Weighing Gene Coexpression Network. BioMed Research International 2022;2022:1-17. [DOI: 10.1155/2022/2244228] [Reference Citation Analysis]
2 Wang J, Qiu X, Huang J, Zhuo Z, Chen H, Zeng R, Wu H, Guo K, Yang Q, Ye H, Huang W, Luo Y. Development and validation of a novel mitophagy-related gene prognostic signature for glioblastoma multiforme. BMC Cancer 2022;22:644. [PMID: 35692054 DOI: 10.1186/s12885-022-09707-w] [Reference Citation Analysis]
3 Sachdeva A, Hart CA, Carey CD, Vincent AE, Greaves LC, Heer R, Oliveira P, Brown MD, Clarke NW, Turnbull DM. Automated quantitative high-throughput multiplex immunofluorescence pipeline to evaluate OXPHOS defects in formalin-fixed human prostate tissue. Sci Rep 2022;12:6660. [PMID: 35459777 DOI: 10.1038/s41598-022-10588-z] [Reference Citation Analysis]
4 Bao L, Xu T, Lu X, Huang P, Pan Z, Ge M. Metabolic Reprogramming of Thyroid Cancer Cells and Crosstalk in Their Microenvironment. Front Oncol 2021;11:773028. [PMID: 34926283 DOI: 10.3389/fonc.2021.773028] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
5 Rakotomalala A, Escande A, Furlan A, Meignan S, Lartigau E. Hypoxia in Solid Tumors: How Low Oxygenation Impacts the "Six Rs" of Radiotherapy. Front Endocrinol (Lausanne) 2021;12:742215. [PMID: 34539584 DOI: 10.3389/fendo.2021.742215] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
6 Tan YQ, Zhang X, Zhang S, Zhu T, Garg M, Lobie PE, Pandey V. Mitochondria: The metabolic switch of cellular oncogenic transformation. Biochim Biophys Acta Rev Cancer 2021;1876:188534. [PMID: 33794332 DOI: 10.1016/j.bbcan.2021.188534] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
7 Wang H, Ma Z, Cheng X, Tuo B, Liu X, Li T. Physiological and Pathophysiological Roles of Ion Transporter-Mediated Metabolism in the Thyroid Gland and in Thyroid Cancer. Onco Targets Ther 2020;13:12427-41. [PMID: 33299328 DOI: 10.2147/OTT.S280797] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Roda N, Gambino V, Giorgio M. Metabolic Constrains Rule Metastasis Progression. Cells 2020;9:E2081. [PMID: 32932943 DOI: 10.3390/cells9092081] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
9 Wang Z, Qiu X, Zhang H, Li W. KLF5 influences cell biological function and chemotherapy sensitivity through the JNK signaling pathway in anaplastic thyroid carcinoma. J Biochem Mol Toxicol 2020;34:e22469. [PMID: 32173973 DOI: 10.1002/jbt.22469] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
10 Wen SS, Zhang TT, Xue DX, Wu WL, Wang YL, Wang Y, Ji QH, Zhu YX, Qu N, Shi RL. Metabolic reprogramming and its clinical application in thyroid cancer. Oncol Lett 2019;18:1579-84. [PMID: 31423225 DOI: 10.3892/ol.2019.10485] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
11 Abooshahab R, Gholami M, Sanoie M, Azizi F, Hedayati M. Advances in metabolomics of thyroid cancer diagnosis and metabolic regulation. Endocrine 2019;65:1-14. [PMID: 30937722 DOI: 10.1007/s12020-019-01904-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
12 Heinemeyer T, Stemmet M, Bardien S, Neethling A. Underappreciated Roles of the Translocase of the Outer and Inner Mitochondrial Membrane Protein Complexes in Human Disease. DNA Cell Biol 2019;38:23-40. [PMID: 30481057 DOI: 10.1089/dna.2018.4292] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
13 Ahmed MAH, Ali MH, Abbas HH, Elatrash GA, Foda AAM. Expression of TOMM34 and Its Clinicopathological Correlations in Urothelial Carcinoma of the Bladder. Pathol Oncol Res 2020;26:411-8. [PMID: 30382527 DOI: 10.1007/s12253-018-0524-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
14 Curry JM, Johnson J, Mollaee M, Tassone P, Amin D, Knops A, Whitaker-Menezes D, Mahoney MG, South A, Rodeck U, Zhan T, Harshyne L, Philp N, Luginbuhl A, Cognetti D, Tuluc M, Martinez-Outschoorn U. Metformin Clinical Trial in HPV+ and HPV- Head and Neck Squamous Cell Carcinoma: Impact on Cancer Cell Apoptosis and Immune Infiltrate. Front Oncol. 2018;8:436. [PMID: 30364350 DOI: 10.3389/fonc.2018.00436] [Cited by in Crossref: 13] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
15 Xiong Y, Liu W, Huang Q, Wang J, Wang Y, Li H, Fu X. Tigecycline as a dual inhibitor of retinoblastoma and angiogenesis via inducing mitochondrial dysfunctions and oxidative damage. Sci Rep 2018;8:11747. [PMID: 30082885 DOI: 10.1038/s41598-018-29938-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
16 Wilde L, Tanson K, Curry J, Martinez-outschoorn U. Autophagy in cancer: a complex relationship. Biochemical Journal 2018;475:1939-54. [DOI: 10.1042/bcj20170847] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 8.8] [Reference Citation Analysis]
17 Lv Z, Yan X, Lu L, Su C, He Y. Atovaquone enhances doxorubicin’s efficacy via inhibiting mitochondrial respiration and STAT3 in aggressive thyroid cancer. J Bioenerg Biomembr 2018;50:263-70. [DOI: 10.1007/s10863-018-9755-y] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
18 Ma L, Cheng Q. Inhibiting 6-phosphogluconate dehydrogenase reverses doxorubicin resistance in anaplastic thyroid cancer via inhibiting NADPH-dependent metabolic reprogramming. Biochem Biophys Res Commun 2018;498:912-7. [PMID: 29534964 DOI: 10.1016/j.bbrc.2018.03.079] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
19 Gooptu M, Whitaker-Menezes D, Sprandio J, Domingo-Vidal M, Lin Z, Uppal G, Gong J, Fratamico R, Leiby B, Dulau-Florea A, Caro J, Martinez-Outschoorn U. Mitochondrial and glycolytic metabolic compartmentalization in diffuse large B-cell lymphoma. Semin Oncol 2017;44:204-17. [PMID: 29248132 DOI: 10.1053/j.seminoncol.2017.10.002] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 3.4] [Reference Citation Analysis]
20 Wilde L, Roche M, Domingo-Vidal M, Tanson K, Philp N, Curry J, Martinez-Outschoorn U. Metabolic coupling and the Reverse Warburg Effect in cancer: Implications for novel biomarker and anticancer agent development. Semin Oncol 2017;44:198-203. [PMID: 29248131 DOI: 10.1053/j.seminoncol.2017.10.004] [Cited by in Crossref: 111] [Cited by in F6Publishing: 137] [Article Influence: 22.2] [Reference Citation Analysis]
21 Lee AR, Park J, Jung KJ, Jee SH, Kim-Yoon S. Genetic variation rs7930 in the miR-4273-5p target site is associated with a risk of colorectal cancer. Onco Targets Ther 2016;9:6885-95. [PMID: 27853382 DOI: 10.2147/OTT.S108787] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
22 Wang L, Ladurner A, Latkolik S, Schwaiger S, Linder T, Hošek J, Palme V, Schilcher N, Polanský O, Heiss EH, Stangl H, Mihovilovic MD, Stuppner H, Dirsch VM, Atanasov AG. Leoligin, the Major Lignan from Edelweiss (Leontopodium nivale subsp. alpinum), Promotes Cholesterol Efflux from THP-1 Macrophages. J Nat Prod 2016;79:1651-7. [PMID: 27220065 DOI: 10.1021/acs.jnatprod.6b00227] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
23 Gill KS, Tassone P, Hamilton J, Hjelm N, Luginbuhl A, Cognetti D, Tuluc M, Martinez-Outschoorn U, Johnson JM, Curry JM. Thyroid Cancer Metabolism: A Review. J Thyroid Disord Ther 2016;5:200. [PMID: 27213120 DOI: 10.4172/2167-7948.1000200] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]